Extensive research has identified IL-13Rα2 overexpression not only in glioblastoma multiforme (GBM) but also in advanced stages of BCA, where it correlates with poor prognosis and enhanced metastatic capability [3,12,13]. This evidence concerns the gene IL13RA2 and glioblastoma.